Casgevy
The MHRA is the first Regulatory body in the world to authorise a Crispr-based gene therapy.
Arrangements for primary care services during the Funeral of HM Queen Elizabeth II on Monday 19th September
With the very sad passing of Her Majesty Queen Elizabeth II, plans are underway for arrangements for primary care services ahead of her funeral on Monday the 19th of September …
Pressure on the NHS is set to increase
In an unprecedented move NHS bosses appeal to the Government to address rising costs before the winter causes a public health emergency.
National Patient Safety Alert: Fears over Safety of Potassium Permanganate Use
t National Patient Safety Team, and the British Association of Dermatologists, on the risk of inadvertent oral administration of potassium permanganate and the fear over safety when used.
Pharmacogenomic Tests ground-breaking Tests to revolutionise medicine
As early as next year pharmacogenomic tests could be made available on the NHS.
Mobocertinib – Eligible Lung Cancer patients in England to be offered innovative treatment
Mobocertinib has now been fast-tracked and will be made available to NHS England eligible lung cancer patients within weeks.